Biomedical Science Careers Program (BSCP)

April, 2024

April 2024 Ness Keynote Speaker: Jose C. Florez, M.D., Ph.D.

ASCI Perspectives: Jose C. Florez, MD, PhD

December, 2023

DEIC Committee member Dr. Vijay Sankaran interviewed Jose C. Florez, MD, PhD (view profile), who serves as Physician-in-Chief and Chair of the Department of Medicine at Massachusetts General Hospital, Professor of Medicine at Harvard Medical School, and a member of the Broad Institute of MIT and Harvard. Dr. Florez’s lab has conducted and analyzed high-throughput genomic studies in type 2 diabetes. As MGH chair, he oversees numerous faculty members and trainees. In this interview, Dr. Florez discusses how genomic medicine can transform patient care, as well as the importance of being open to change in one’s career.

Uroczysta Inauguracja Roku Akademickiego 2023/2024

October, 2023

“The Practice of Medicine in the 21st Century”

Inaugural Lecture of the Academic Year 2023-2024

Medical University of Bialystok

Massachusetts General Hospital Medical Grand Rounds

October, 2023

“A Vision for the Department of Medicine at MGH”

Jose C. Florez, MD, PhD

Physician-in-Chief and Chair, Department of Medicine, MGH

Investigator, Center for Genomic Medicine, MGH

Institute Member, Broad Institute

Professor of Medicine, Harvard Medical School

New partnership seeks to treat cause of diabetes

September, 2023

The Broad Institute and Novo Nordisk have formed a research partnership.

Tackling Diabetes From Every Angle

September, 2021

Physicians, geneticists, chemists, and other researchers in Broad’s Diabetes Research Group are working together and taking multiple approaches to improve treatment for patients with diabetes.


ADA 2019 – Diabetes Research Across the Spectrum

June, 2019

Jose C Florez joins us at the ADA annual meeting 2019 to discuss his presentation on diabetes research across the spectrum – from cell-based to clinical translation.

Filmed at the American Diabetes Association (ADA) annual meeting 2019, San Francisco, USA

1) What are the major obstacles to achieving personalised medicine in diabetes?
2) What is the role of epigenetic changes in the progression of type 1 and type 2 diabetes?
3) How will increased understanding of these changes affect the management of patients of diabetes?
4) What further research is needed to elucidate the genetic architecture of type 2 diabetes?
5) What recent advances in translational research in diabetes have excited you most?

Highlights of the ADA 79th Scientific Sessions

June, 2019

We take a look at some of the highlights of the last two days of the ADA 79th Scientific Sessions, and who better to take a look at the program with us than ADA Scientific Sessions planning committee chair Dr Jose Florez.

Massive NIH–industry project opens portals to target validation

February, 2019

Five years in, the US$360 million Accelerating Medicines Partnership is yielding tools to speed up drug discovery for rheumatoid arthritis, lupus, diabetes, Alzheimer disease and Parkinson disease.

DNA analysis identifies five subtypes of type two diabetes

September, 2018